Warner Bros. Discovery Beats EPS Estimates Despite Revenue Miss on NBA Deal Loss

Key Facts

Amid a critical period for media conglomerates, Warner Bros. Discovery reported a significant Q2 2026 earnings beat with an EPS of $0.06, defying analyst expectations of a $0.14 loss. However, the company's total revenue of $8.72 billion fell short of the $9.25 billion consensus, primarily due to the loss of a key NBA broadcasting deal. Despite the top-line miss, the streaming segment emerged as a bright spot, generating record revenue exceeding $3 billion and a 60% surge in adjusted EBITDA to $512 million.

This performance highlights a shifting landscape where streaming growth is battling traditional broadcasting headwinds. Per market data, while WBD navigates these structural changes, biotech peers like Iovance Biotherapeutics and Evolent Health continue to show strong momentum, with the latter raising its 2026 revenue guidance to a range of $2.6 billion to $2.7 billion. The contrast between WBD's streaming success and its sports licensing setbacks remains a central theme for sector analysts.

Regarding market levels, WBD stood at $25.97 at close August 05, 2026, after trading within a range of $25.58 to $26.01. Investors should monitor whether the record streaming margins can offset the revenue gap left by the NBA contract in upcoming quarters, while keeping an eye on broader market volatility.